Impact of Angiotensin Receptor Neprilysin Inhibitor on Chronic Heart Failure with Reduced Ejection Fraction in Adult Congenital Heart Disease Patients: A Systematic Review and Meta-analysis

被引:0
|
作者
Das, Bibhuti
Deshpande, Shriprasad
Nikolaidis, Lazaros
Hernandez-Montfort, Jaime
Niu, Jianli
机构
关键词
D O I
10.1161/circ.150.suppl_1.4143312
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
4143312
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Combined neprilysin and renin-angiotensin system inhibition in heart failure with reduced ejection fraction: a meta-analysis
    Solomon, Scott D.
    Claggett, Brian
    McMurray, John J. V.
    Hernandez, Adrian F.
    Fonarow, Gregg C.
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 (10) : 1238 - 1243
  • [22] Cost-Effectiveness of Earlier Transition to Angiotensin Receptor Neprilysin Inhibitor in Patients With Heart Failure and Reduced Ejection Fraction
    Grant, Andrew D. M.
    Chew, Derek S.
    Howlett, Jonathan G.
    Miller, Robert J. H.
    CJC OPEN, 2020, 2 (06) : 447 - 453
  • [23] Role of angiotensin receptor blockers in chronic heart failure with reduced left ventricular ejection fraction: a meta-analysis
    Wang, Yushu
    Kang, Yu
    Wan, Ke
    Wen, Meiqing
    Zhou, Junteng
    Zhang, Qing
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (02): : 978 - 990
  • [24] Heart failure with reduced and preserved ejection fraction in adult congenital heart disease
    Sumeet S. Vaikunth
    George K. Lui
    Heart Failure Reviews, 2020, 25 : 569 - 581
  • [25] Heart failure with reduced and preserved ejection fraction in adult congenital heart disease
    Vaikunth, Sumeet S.
    Lui, George K.
    HEART FAILURE REVIEWS, 2020, 25 (04) : 569 - 581
  • [26] Timing of angiotensin receptor-neprilysin inhibitor initiation in patients with heart failure and reduced ejection fraction: data from the Swedish heart failure registry
    Stolfo, D.
    Lund, L.
    Benson, L.
    Kack, O.
    Lindberg, F.
    Sinagra, G.
    Dahlstrom, U.
    Savarese, G.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [27] Real world experience on angiotensin receptor and neprilysin inhibition in reduced ejection fraction heart failure patients with advanced chronic kidney disease
    Hsu, C. Y.
    Chang, H. Y.
    EUROPEAN HEART JOURNAL, 2020, 41 : 936 - 936
  • [28] Phosphodiesterase inhibitor for heart failure with preserved ejection fraction: A systematic review and meta-analysis
    Chen, Zhu
    Zhao, Kaixuan
    Xiao, Changhu
    He, Ziyu
    Liu, Sha
    Wu, Xuemei
    Shi, Shuting
    Guo, Yuan
    SAUDI PHARMACEUTICAL JOURNAL, 2022, 30 (08) : 1079 - 1087
  • [29] The Angiotensin Receptor Neprilysin Inhibitor LCZ696 is Effective Across the Spectrum of Ejection Fraction in Heart Failure With Reduced Ejection Fraction
    Solomon, Scott
    Packer, Milton
    Zile, Michael
    Swedberg, Karl
    Rouleau, Jean
    Letkowitz, Martin
    Shi, Victor
    Desai, Akshay
    Claggett, Brian
    Starling, Randall
    McMurray, John J. V.
    JOURNAL OF CARDIAC FAILURE, 2015, 21 (08) : S45 - S46
  • [30] Global use of angiotensin receptor neprilysin inhibitor in heart failure and reduced, below normal and supranormal ejection fraction
    Horiuchi, Yu
    Asami, Masahiko
    Yahagi, Kazuyuki
    Oshima, Asahi
    Gonda, Yuki
    Yoshiura, Daiki
    Komiyama, Kota
    Yuzawa, Hitomi
    Tanaka, Jun
    Aoki, Jiro
    Tanabe, Kengo
    HEART AND VESSELS, 2025, 40 (03) : 227 - 234